BrainQ Technologies Named to Fast Company’s Annual List of the Next Big Things in Tech


By: BrainQ Team

Company Updates

BrainQ is honored as one of Fast Company's "Next Big Things in Tech"
List Recognizes Tech Breakthroughs Across Industries That Promise to Transform the Future

[Jerusalem, IL], November 28, 2023 — BrainQ Technologies, a pioneering company at the forefront of brain longevity therapeutics, announced that it has been named to Fast Company’s annual Next Big Things in Tech list, honoring technology breakthroughs that promise to shape the future of industries—from healthcare and security to artificial intelligence and data.

“Stroke is the leading cause of long-term disability, affecting millions of patients worldwide. Our Fast Company nomination of BrainQ further reaffirms our mission and our journey to curing stroke disability”  says Yotam Drechsler CEO and Co-founder of BrainQ. 

 

“The Next Big Things in Tech is not just a look around the corner—it's a look around the corner after that,” says Brendan Vaughan, editor-in-chief of Fast Company. “These are the products and ideas that will define technological innovation for the rest of this decade and beyond—and solve some of the world's most pressing issues. We are thrilled to honor the organizations that are making them a reality.”

Click here to see the final list.

The Winter 2023/2024 issue of Fast Company is available online now and will hit newsstands on December 5.

 

About Fast Company

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Brendan Vaughan. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

 

About BrainQ

BrainQ is a pioneering brain longevity therapeutics company. The company has received an FDA Breakthrough Device Designation for its first product for Stroke disability.